Stock of the Day for November 6, 2024

McKesson Stock Report

McKesson
MCK 90-day performance NYSE:MCK McKesson
Current Price
$855.70
-1.07 (-0.13%)
(As of 04/7/2026 03:59 PM ET)
30 Day Performance
-9.08%
  
  
90 Day Performance
5.07%
  
 
1 Year Performance
31.06%
  
 
Market Capitalization
$104.81B
P/E Ratio
24.61
Dividend Yield
0.38%

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers. McKesson also offers a range of technology and automation solutions — including pharmacy automation, supply chain management software, and analytics — designed to improve operational efficiency, inventory control and patient safety for its customers. In addition, the firm provides support services such as clinical program management, patient access and adherence services for specialty therapies, and commercial services for biopharma manufacturers.

McKesson serves a broad customer base that includes retail and independent pharmacies, long-term care providers, hospitals and health systems, physician offices and specialty clinics. While its operations are concentrated in the United States and Canada, the company works with global pharmaceutical manufacturers and participates in international supply chain activities. Its business model emphasizes integration between distribution, technology and services to support the delivery of medications and related care.

Led by a corporate management team focused on resilience and technology-enabled solutions, McKesson has leveraged its long history in healthcare distribution to prioritize supply chain reliability, digital transformation and expanded services for specialty and complex therapies. The company’s combination of logistics capabilities, service offerings and health-technology products positions it as a key intermediary in the U.S. healthcare system.

MCK Company Calendar

FEB. 4, 2026
Last Earnings
MAR. 2, 2026
Ex-Dividend for 4/1 Dividend
APR. 1, 2026
Dividend Payable
APR. 8, 2026
Today
MAY. 7, 2026
Next Earnings (Estimated)
MAR. 31, 2027
Fiscal Year End

Recent McKesson News

Bank of America Issues Pessimistic Forecast for McKesson (NYSE:MCK) Stock Price
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
BofA Lowers McKesson (MCK) Price Target, Flags GLP-1 Pricing Pressure
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
5 Best Consistent Dividend Stocks to Buy Right Now
McKesson (NYSE:MCK) Price Target Lowered to $1,000.00 at Bank of America
Is Medline Inc. (MDLN) A Good Stock To Buy Now?
The Oncology Institute Names Minh Merchant Chief Legal Officer
McKesson Secures New $2 Billion Senior Credit Facilities
Rathbones Group PLC Sells 14,594 Shares of McKesson Corporation $MCK
This report was written by MarketBeat.com on April 8, 2026. This report first appeared on MarketBeat.com.